UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 112

Sortiert nach

Transthyretin Cardiac Amyloidosis in Older Americans

Journal of cardiac failure, 2016-12, Vol.22 (12), p.996-1003

2016

Link zum Volltext

Verfügbarkeit prüfen

Transthyretin Cardiac Amyloidosis in Black Americans

Circulation. Heart failure, 2016-06, Vol.9 (6), p.e002558-e002558

2016

Link zum Volltext

Verfügbarkeit prüfen

Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story

Drug design, development and therapy, 2021-01, Vol.15, p.1225-1243

2021

Link zum Volltext

Verfügbarkeit prüfen

Wild-type Transthyretin Cardiac Amyloidosis: Novel Insights from Advanced Imaging

Canadian journal of cardiology, 2016-09, Vol.32 (9), p.1166.e1-1166.e10

2016

Link zum Volltext

Verfügbarkeit prüfen

Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

Heart failure reviews, 2015-03, Vol.20 (2), p.163-178

2015

Link zum Volltext

Verfügbarkeit prüfen

Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

European heart journal, 2017-10, Vol.38 (38), p.2879-2887

2017

Link zum Volltext

Verfügbarkeit prüfen

A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy

Nature communications, 2021-05, Vol.12 (1), p.2725-2725, Article 2725

2021

Link zum Volltext

Verfügbarkeit prüfen

Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction

European heart journal, 2015-10, Vol.36 (38), p.2595-2597

2015

Link zum Volltext

Verfügbarkeit prüfen

Prognosticating in Cardiac Amyloidosis: Let Me Count the Ways

JACC. Cardiovascular imaging, 2019-05, Vol.12 (5), p.834-836

2019

Link zum Volltext

Verfügbarkeit prüfen

Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis

European journal of heart failure, 2021-02, Vol.23 (2), p.250-258

2021

Link zum Volltext

Verfügbarkeit prüfen

Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis

Journal of nuclear cardiology, 2018-02, Vol.25 (1), p.181-190

2018

Link zum Volltext

Verfügbarkeit prüfen

Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges

Heart failure reviews, 2021-01, Vol.26 (1), p.35-45

2021

Link zum Volltext

Verfügbarkeit prüfen

Nuclear imaging modalities for cardiac amyloidosis

Journal of nuclear cardiology, 2014-02, Vol.21 (1), p.175-184

2014

Link zum Volltext

Verfügbarkeit prüfen

99mTc-Pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses

Circulation. Cardiovascular imaging, 2013-03, Vol.6 (2), p.195-201

2013

Link zum Volltext

Verfügbarkeit prüfen

Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population

The American journal of cardiology, 2022-03, Vol.167, p.98-103

2022

Link zum Volltext

Verfügbarkeit prüfen

Estimating Cancer Risk from Tc-99m Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis

Journal of nuclear cardiology, 2020-02, Vol.27 (1), p.215-224

2020

Link zum Volltext

Verfügbarkeit prüfen

Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis

Journal of nuclear cardiology, 2016-12, Vol.23 (6), p.1355-1363

2016

Link zum Volltext

Verfügbarkeit prüfen

TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis

Circulation. Heart failure, 2018-04, Vol.11 (4), p.e004769-e004769

2018

Link zum Volltext

Verfügbarkeit prüfen

Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor

Journal of clinical neuromuscular disease, 2016-03, Vol.17 (3), p.142

2016

Link zum Volltext

Verfügbarkeit prüfen

Could Late Enhancement and Need for Permanent Pacemaker Implantation in Patients Undergoing TAVR Be Explained by Undiagnosed Transthyretin Cardiac Amyloidosis?

Journal of the American College of Cardiology, 2015-01, Vol.65 (3), p.311-312

2015

Link zum Volltext

Verfügbarkeit prüfen

Technetium 99m pyrophosphate radioisotope for diagnosis and prognosis of transthyretin cardiac amyloidosis: A call for collaboration

Journal of nuclear cardiology, 2018-08, Vol.25 (4), p.1257-1259

2018

Link zum Volltext

Verfügbarkeit prüfen

Coronary artery pathophysiology after radiofrequency catheter ablation: Review and perspectives

Heart rhythm, 2011-12, Vol.8 (12), p.1975-1980

2011

Link zum Volltext

Verfügbarkeit prüfen

US CARDIOLOGIST AND PATIENT PERSPECTIVES ON COVID-19 TELEHEALTH PRACTICES FOR PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM)

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.690-690

2021

Link zum Volltext

Verfügbarkeit prüfen

Diflunisal for ATTR Cardiac Amyloidosis

Congestive heart failure (Greenwich, Conn.), 2012-11, Vol.18 (6), p.315-319

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 112

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(102)

Publikationsform

Sprache

Englisch
(110)
Japanisch
(19)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Humans
(50)
Life Sciences & Biomedicine
(49)
Cardiac & Cardiovascular Systems
(21)
Cardiovascular System & Cardiology
(21)
Cardiology
(20)
Male
(20)
Female
(18)
Aged
(16)
Amyloidosis
(15)
Medicine
(13)
Medicine & Public Health
(13)
Cardiology And Cardiovascular Medicine
(11)
Heart Failure
(11)
Cardiomyopathy
(10)
Cardiovascular
(10)
Middle Aged
(10)
Cardiomyopathies - Diagnostic Imaging
(9)
Patients
(9)
Radiology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Transthyretin Cardiac Amyloidosis in Older Americans

Transthyretin Cardiac Amyloidosis in Black Americans

Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story

Wild-type Transthyretin Cardiac Amyloidosis: Novel Insights from Advanced Imaging

Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy

Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction

Prognosticating in Cardiac Amyloidosis: Let Me Count the Ways

Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis

Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis

Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges

Nuclear imaging modalities for cardiac amyloidosis

99mTc-Pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses

Temporal Trends in Diagnostic Testing Patterns for Wild-Type Transthyretin Amyloid Cardiomyopathy in the Medicare Fee-for-Service Population

Estimating Cancer Risk from Tc-99m Pyrophosphate Imaging for Transthyretin Cardiac Amyloidosis

Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis

TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis

Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor

Could Late Enhancement and Need for Permanent Pacemaker Implantation in Patients Undergoing TAVR Be Explained by Undiagnosed Transthyretin Cardiac Amyloidosis?

Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis

Technetium 99m pyrophosphate radioisotope for diagnosis and prognosis of transthyretin cardiac amyloidosis: A call for collaboration

Coronary artery pathophysiology after radiofrequency catheter ablation: Review and perspectives

US CARDIOLOGIST AND PATIENT PERSPECTIVES ON COVID-19 TELEHEALTH PRACTICES FOR PATIENTS WITH TRANSTHYRETIN AMYLOID CARDIOMYOPATHY (ATTR-CM)

Diflunisal for ATTR Cardiac Amyloidosis

Suchergebnisse filtern